![Daljit Singh Aurora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daljit Singh Aurora
Geschäftsführer bei
NEUMORA THERAPEUTICS, INC.
Vermögen: 64 838 $ am 31.08.2026
Profil
Daljit Singh Aurora is currently Chief Operating & Development Officer at Neumora Therapeutics, Inc. since 2025.
Former positions include Chief Scientific Affairs Officer at Dermira, Inc. from 2019 to 2021, Vice President-Medical Affairs at Neurocrine Biosciences, Inc. from 2015 to 2016, Vice President-Scientific Affairs at Merck Research Laboratories Massachusetts LLC from 2014 to 2015, and VP-Worldwide Compliance & Business Ethics at Amgen, Inc. from 2013 to 2014.
Education includes undergraduate studies at The University of Texas at Austin and a doctorate from The University of Texas Health Science Center at Houston.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.08.2026 | 48.750 ( 0,03 % ) | 64 838 $ | 31.08.2026 |
Aktive Positionen von Daljit Singh Aurora
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Geschäftsführer | 14.02.2025 |
Ehemalige bekannte Positionen von Daljit Singh Aurora
| Unternehmen | Position | Ende |
|---|---|---|
| DERMIRA, INC. | Compliance Officer | 01.11.2019 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01.07.2016 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 01.04.2015 |
| AMGEN INC. | Corporate Officer/Principal | 01.09.2014 |
Ausbildung von Daljit Singh Aurora
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
The University of Texas Health Science Center at Houston
 The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
